| Storz, Peter |
Mayo Clinic Jacksonville
United States |
Deiminated molecules as markers for developing pancreatic cancer - A1 |
1R21CA279916-01A1 |
|
Matthew Young, Ph.D. |
| Stolley, Melinda R |
Medical College Of Wisconsin
United States |
Every Day Counts: A lifestyle program for women metastatic breast cancer |
5R01CA258759-03 |
PAR-18-893 (R01 Clinical Trial Optional) |
|
| Stolley, Melinda R |
Medical College Of Wisconsin
United States |
Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors |
3R01CA229546-05S1 |
|
Sharon Ross, Ph.D., M.P.H. |
| Staff, Nathan P |
Mayo Clinic Rochester
United States |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity |
5R01CA275870-02 |
PAR-21-329 (R01 Clinical Trial Optional) |
Rachel Altshuler, Ph.D. |
| Stachler, Matthew D |
University Of California, San Francisco
United States |
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus |
5R37CA269649-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Matthew Young, Ph.D. |
| Stabile, Laura P. |
University Of Pittsburgh At Pittsburgh
United States |
Super-Resolution Imaging of Higher-Order Heterochromatin Structure for Early Detection of Lung Carcinogenesis |
5R21CA259787-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Claire Zhu, Ph.D. |
| Spira, Avrum E |
Boston University Medical Campus
United States |
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy |
1U2CCA233238-01 |
|
Richard Mazurchuk, Ph.D. |
| Spiegel, Brennan |
Cedars-Sinai Medical Center
United States |
Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
5R01CA252211-04 |
|
Rachel Altshuler, Ph.D. |
| Sowers, Lawrence C |
University Of Texas Med Br Galveston
United States |
Cytosine Deamination Adducts and Cancer Etiology |
5R01CA228085-05 |
|
Wendy Wang, Ph.D., M.Sc. |
| Sorror, Mohamed |
Fred Hutchinson Cancer Center
United States |
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality |
5R01CA227092-06 |
|
|